Overview

Study of AT-527 in Subjects With Normal and Impaired Renal Function

Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
Study of AT-527 in Subjects with Normal and Impaired Renal Function
Phase:
Phase 1
Details
Lead Sponsor:
Atea Pharmaceuticals, Inc.
Treatments:
Probenecid